1. Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance.
   Tarek Mazzawi et al, 2015, Gastroenterol Res Pract CrossRef
2. Stomach antral endocrine cells in patients with irritable bowel syndrome
   MAGDY EL-SALHY et al, 2014 CrossRef
3. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome
   Magdy El-Salhy et al, 2015, Peptides CrossRef
4. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance.
   Tarek Mazzawi et al, 2016, Int. J. Mol. Med. CrossRef
5. Interaction between diet and gastrointestinal endocrine cells
   MAGDY EL-SALHY et al, 2016 CrossRef
6. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
   Magdy El-Salhy et al, 2013, Mol Med Rep CrossRef
7. Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).
   Magdy El-Salhy et al, 2014, Int J Mol Med CrossRef
8. Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome
   Tarek Mazzawi et al, 2016 CrossRef
9. Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome
   Magdy El-Salhy et al, 2017, Scandinavian Journal of Gastroenterology CrossRef
10. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease
    MAGDY EL-SALHY et al, 2013 CrossRef
11. Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome.
    Tarek Mazzawi et al, 2014, Mol Med Rep CrossRef
12. Recent developments in the pathophysiology of irritable bowel syndrome
    Magdy El-Salhy, 2015, WJG CrossRef
13. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome
    Magdy El-Salhy, 2014, WJGE CrossRef
14. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome.
    Magdy El-Salhy et al, 2014, Mol Med Rep CrossRef
15. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review)
    Tarek Mazzawi et al, 2017 CrossRef
16. Implications of Pharmacogenomics to the Management of IBS
    Michael Camilleri, 2018, Clinical Gastroenterology and Hepatology CrossRef
17. Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects
    Johanna Sundin et al, 2018, Sci Rep CrossRef
18. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report
    Magdy El-Salhy et al, 2013, BMC Res Notes CrossRef
19. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome.
    T Mazzawi et al, 2016, Eur J Clin Nutr CrossRef
20. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS
    Lena Öhman et al, 2015, Nat Rev Gastroenterol Hepatol CrossRef
21. Abnormal rectal endocrine cells in patients with irritable bowel syndrome
    Magdy El-Salhy et al, 2014, Regulatory Peptides CrossRef
22. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment.
    Magdy El-Salhy et al, 2014, Expert Rev Gastroenterol Hepatol CrossRef
23. Diet and Irritable Bowel Syndrome, with a Focus on Appetite-Regulating Gut Hormones
    Magdy El-Salhy et al, 2014 CrossRef
24. Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity
    Sanda Pletikosic et al, 2015, Medical Hypotheses CrossRef
25. Recent advances in the diagnosis of irritable bowel syndrome
    Magdy El-Salhy, 2015, Expert Review of Gastroenterology & Hepatology CrossRef
26. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome
    Magdy El-Salhy et al, 2017, Expert Review of Gastroenterology & Hepatology CrossRef
27. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome
    Magdy El-Salhy et al, 2017, Scandinavian Journal of Gastroenterology CrossRef
28. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome
    Magdy El-Salhy et al, 2017, BMC Gastroenterol CrossRef
29. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS)
    Magdy El-Salhy et al, 2019, Neuropeptides CrossRef
30. The pro-inflammatory cytokines IFNγ/TNFα increase chromogranin A-positive neuroendocrine cells in the colonic epithelium
    José Antonio Hernández-Trejo et al, 2016 CrossRef
31. Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome
    Magdy El-Salhy, 2020, WJG CrossRef